Home/Filings/4/0001169245-21-000126
4//SEC Filing

Hanson Kristopher 4

Accession 0001169245-21-000126

CIK 0001169245other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 6:51 PM ET

Size

4.9 KB

Accession

0001169245-21-000126

Insider Transaction Report

Form 4
Period: 2021-11-19
Hanson Kristopher
Vice President, Head of Legal
Transactions
  • Award

    Common Stock

    2021-11-19$2.01/sh+1,545$3,1053,632 total
Footnotes (1)
  • [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001789970

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:51 PM ET
Size
4.9 KB